Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 0.51 -15.82%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Lineage Cell Therapeutics Gross Profit 2011-2024 | LCTX

Annual Gross Profit Lineage Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
8.27 M 14 M 2.92 M 1.44 M 3.1 M 4.69 M 3.29 M 5.56 M 5.93 M 4.41 M 3.64 M 3.48 M 4.35 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
14 M 1.44 M 5 M

Quarterly Gross Profit Lineage Cell Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - 1.08 M 3.1 M 2.27 M - 2.76 M 4.34 M 5.06 M - 1.28 M 387 K 279 K - 469 K 311 K 420 K - 453 K 672 K 860 K - 947 K 2.44 M 592 K - 1.64 M 376 K 333 K - 1.44 M 1.17 M 1.85 M - 1.87 M 1.75 M 1 M - 960 K 855 K 935 K - 507 K 1.04 M 432 K - 834 K 950 K 632 K - 1.14 M 756 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
5.06 M 279 K 1.27 M